Nephropathic cystinosis: An international consensus document

Nephrology Dialysis Transplantation

Volumn 29, Issue , 2014, Pages iv87-iv94

  Emma, Francesco ^a   Nesterova, Galina ^b   Langman, Craig ^c   Labbé, Antoine ^d,e   Cherqui, Stephanie ^f   Goodyer, Paul ^g   Janssen, Mirian C ^h   Greco, Marcella ^a   Topaloglu, Rezan ⁱ   Elenberg, Ewa ^j   Dohil, Ranjan ^f   Trauner, Doris ^k   Antignac, Corinne ^l,m,n   Cochat, Pierre ^o   Kaskel, Frederick ^p   Servais, Aude ⁿ   Wühl, Elke ^q   Niaudet, Patrick ^r   Van't Hoff, William ^s   Gahl, William ^b   Levtchenko, Elena ^t   more..

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^e CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^g MONTREAL CHILDREN S HOSPITAL   (Canada)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ HACETTEPE UNIVERSITY   (Turkey)

^j BAYLOR COLLEGE OF MEDICINE   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l INSERM   (France)

^m PARIS DESCARTES SORBONNE PARIS CITÉ UNIVERSITY   (France)

ⁿ HÔPITAL NECKER ENFANTS MALADES   (France)

^o UNIVERSITÉ LYON 1   (France)

^p CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^q UNIVERSITY OF HEIDELBERG   (Germany)

^r UNIVERSITÉ PARIS DESCARTES   (France)

^s GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^t UNIVERSITY HOSPITALS LEUVEN   (Belgium)

more..

Author keywords

CTNS gene; Cysteamine treatment; Cystinosis; Extra renal complications; Renal Fanconi syndrome

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CORTICOSTEROID; CYSTINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HUMAN GROWTH HORMONE; INDOMETACIN; MERCAPTAMINE; TACROLIMUS;

BLEPHAROSPASM; CLINICAL FEATURE; CONTROLLED CLINICAL TRIAL (TOPIC); CORNEA EROSION; CORNEA NEOVASCULARIZATION; CTNS GENE; CYSTINOSIS; DIET SUPPLEMENTATION; EYE DISEASE; FANCONI RENOTUBULAR SYNDROME; GENE; GENE MUTATION; GENE THERAPY; GENETIC ANALYSIS; GLAUCOMA; GLOMERULUS FILTRATION RATE; GROWTH RETARDATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KERATOPATHY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LEUKOCYTE; NEPHROPATHIC CYSTINOSIS; NONHUMAN; OPTIC NERVE DISEASE; PATHOGENESIS; PHOTOPHOBIA; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RETINA DEGENERATION; RETINOPATHY; REVIEW; CHILD; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; CYSTEAMINE TREATMENT; EXTRA-RENAL COMPLICATIONS; GENETICS; MEDICAL SOCIETY; PRACTICE GUIDELINE; RENAL FANCONI SYNDROME;

CTNS GENE; CYSTEAMINE TREATMENT; CYSTINOSIS; EXTRA-RENAL COMPLICATIONS; RENAL FANCONI SYNDROME;

CHILD; CYSTINOSIS; FANCONI SYNDROME; HUMANS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL;

EID: 84911003377     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu090     Document Type: Review

References (69)

1. Gahl WA, Thoene JG, Schneider JA. Cystinosis. N Engl J Med 2002; 347: 111-121
2. Town M, Jean G, Cherqui S et al. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet 1998; 18: 319-324
3. Kalatzis V, Nevo N, Cherqui S et al. Molecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosin. Hum Mol Genet 2004; 13: 1361-1371
4. Levtchenko E, van den Heuvel L, Emma F et al. Clinical utility gene card for: cystinosis. Eur J Hum Genet 2013 [Epub ahead of print]
5. Forestier L, Jean G, Attard M et al. Molecular characterization of CTNS deletions in nephropathic cystinosis: development of a PCR-based detection assay. Am J Hum Genet 1999; 65: 353-359
6. Wamelink MM, Struys EA, Jansen EE. Sedoheptulokinase deficiency due to a 57-kb deletion in cystinosis patients causes urinary accumulation of sedoheptulose: elucidation of the CARKL gene. Hum Mutat 2008; 29: 532-536
7. Kalatzis V, Cherqui S, Antignac C et al. Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter. EMBO J 2001; 20: 5940-5949
8. Ruivo R, Bellenchi GC, Chen X et al. Mechanism of proton/substrate coupling in the heptahelical lysosomal transporter cystinosin. Proc Natl Acad Sci U S A 2012; 109: E210-E217
9. Raggi C, Luciani A, Nevo N et al. Dedifferentiation and aberrations of the endolysosomal compartment characterize the early stage of nephropathic cystinosis. Hum Mol Genet 2014 [Epub ahead of print]
10. Chevronnay HP, Janssens V, Van Der Smissen P et al. Time-course of pathogenic and adaptive mechanisms in cystinotic 1 mice kidneys. J Am Soc Nephrol 2014 [Epub ahead of print]
11. Mahoney CP, Striker GE. Early development of the renal lesions in infantile cystinosis. Pediatr Nephrol 2000; 15: 50-56
12. Park M, Helip-Wooley A, Thoene J. Lysosomal cystine storage augments apoptosis in cultured human fibroblasts and renal tubular epithelial cells. J Am Soc Nephrol 2002; 13: 2878-2887
13. Park MA, Pejovic V, Kerisit KG et al. Increased apoptosis in cystinotic fibroblasts and renal proximal tubule epithelial cells results from cysteinylation of protein kinase Cdelta. J Am Soc Nephrol 2006; 17: 3167-3175
14. Johnson JL, Napolitano G, Monfregola J et al. Upregulation of the Rab27a-dependent trafficking and secretory mechanisms improves lysosomal transport, alleviates endoplasmic reticulum stress, and reduces lysosome overload in cystinosis. Mol Cell Biol 2013; 33: 2950-2962
15. Sansanwal P, Yen B, Gahl WA et al. Mitochondrial autophagy promotes cellular injury in nephropathic cystinosis. J Am Soc Nephrol 2010; 21: 272-283
16. Bellomo F, Corallini S, Pastore A et al. Modulation of CTNS gene expression by intracellular thiols. Free Radic Biol Med 2010; 48: 865-872
17. Taranta A, Petrini S, Palma A et al. Identification and subcellular localization of a new cystinosin isoform. Am J Physiol Renal Physiol 2008; 294: 1101-1108
18. Taranta A, Petrini S, Citti A et al. Distribution of cystinosin-LKG in human tissues. Histochem Cell Biol 2012; 138: 351-363
19. Wilmer MJ, Kluijtmans LA, van der Velden TJ et al. Cysteamine restores glutathione redox status in cultured cystinotic proximal tubular epithelial cells. Biochim Biophys Acta 2011; 1812: 643-651
20. Markello TC, Bernardini IM, Gahl WA. Improved renal function in children with cystinosis treated with cysteamine. New Engl J Med 1993; 328: 1157-1162
21. Greco M, Brugnara M, Zaffanello M et al. Long-term outcome of nephropathic cystinosis: a 20-year single-center experience. Pediatr Nephrol 2010; 25: 2459-2467
22. Lucky AW, Howley PM, Megyesi K et al. Endocrine studies in cystinosis: compensated primary hypothyroidism. J Pediatr 1977; 91: 204-210
23. Chik CL, Friedman A, Merriam GR et al. Pituitary-testicular function in nephropathic cystinosis. Ann Intern Med 1993; 119: 568-575
24. Besouw MT, Kremer JA, Janssen MC et al. Fertility status in male cystinosis patients treated with cysteamine. Fertil Steril 2010; 93: 1880-1883
25. Reiss RE, Kuwabara T, Smith ML et al. Successful pregnancy despite placental cystine crystals in a woman with nephropathic cystinosis. N Engl J Med 1988; 319: 223-226
26. Robert JJ, Tête MJ, Guest G et al. Diabetes mellitus in patients with infantile cystinosis after renal transplantation. Pediatr Nephrol 1999; 13: 524-529
27. Broyer M, Tete MJ, Gubler MC. Late symptoms in infantile cystinosis. Pediatr Nephrol 1987; 1: 519-524
28. Dohil R, Carrigg A, Newbury R. A potential new method to estimate tissue cystine content in nephropathic cystinosis. J Pediatr. 2012; 161: 531-535.e1
29. Nesterova G, Gahl W. Cystinosis: the evolution of a treatable disease. Pediatr Nephrol 2013; 28: 51-59
30. Bava S, Theilmann RJ, Sach M et al. Developmental changes in cerebral white matter microstructure in a disorder of lysosomal storage. Cortex 2010; 46: 206-216
31. Trauner DA, Spilkin AM, Williams J et al. Specific cognitive deficits in young children with cystinosis: evidence for an early effect of the cystinosin gene on neural function. J Pediatr 2007; 151: 192-196
32. Wilmer MJ, Schoeber JP, van den Heuvel LP et al. Cystinosis: practical tools for diagnosis and treatment. Pediatr Nephrol 2011; 26: 205-215
33. Elenberg E, Norling LL, Kleinman RE et al. Feeding problems in cystinosis. Pediatr Nephrol 1998; 5: 365-370
34. Dohil R, Fidler M, Barshop B et al. Esomeprazole therapy for gastric acid hypersecretion in children with cystinosis receiving cysteamine. Pediatr Nephrol 2005; 20: 1786-1793
35. Haycock GB, Al-Dahhan J, Mak RH et al. Effect of indomethacin on clinical progress and renal function in cystinosis. Arch Dis Child 1982; 57: 934-939
36. Usberti M, Pecoraro C, Federico S et al. Mechanism of action of indomethacin in tubular defects. Pediatrics 1985; 75: 501-507
37. Bennett WM, Henrich WL, Stoff JS. The renal effects of nonsteroidal antiinflammatory drugs: summary and recommendations. Am J Kidney Dis 1996; 28: S56-S62
38. Levtchenko E, Blom H, Wilmer M et al. ACE inhibitor enalapril diminishes albuminuria in patients with cystinosis. Clin Nephrol 2003; 60: 386-389
39. Broyer M, Guillot M, Gubler MC et al. Infantile cystinosis: a reappraisal of early and late symptoms. Adv Nephrol Necker Hosp 1981; 10: 137-166
40. GahlWA, Reed GF, Thoene JG et al. Cysteamine therapy for children with nephropathic cystinosis. New Engl J Med 1987; 316: 971-977
41. Winkler L, Offner G, Krull F et al. Growth and pubertal development in nephropathic cystinosis. Eur J Pediar 1993; 152: 244-249
42. Van Stralen KJ, Emma F, Jager KJ et al. Improvement in the renal prognosis in nephropathic cystinosis. Clin J Am Soc Nephrol 2011; 6: 2485-2491
43. Ehrich JH, Brodehl J, Byrd DI et al. Renal transplantation in 22 children with nephropathic cystinosis. Pediatr Nephrol 1991; 5: 708-714
44. van't Hoff WG, Gretz N. The treatment of cystinosis with cysteamine and phosphocysteamine in the United Kingdom and Eire. Pediatr Nephrol 1995; 9: 685-689
45. Wuhl E, Haffner D, Gretz N et al. Treatment with recombinant human growth hormone in short children with nephropathic cystinosis: no evidence for increased deterioration rate of renal function. The European Study Group on Growth Hormone Treatment in Short Children with Nephropathic Cystinosis. Pediatr Res 1998; 43: 484-488
46. Wuhl E, Haffner D, Offner G et al. Long-term treatment with growth hormone in short children with nephropathic cystinosis. J Pediatr 2001; 138: 880-887
47. Besouw MT, Van Dyck M, Francois I et al. Detailed studies of growth hormone secretion in cystinosis patients. Pediatr Nephrol 2012; 27: 2123-2127
48. Brodin-Sartorius A, Tête MJ, Niaudet P et al. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults. Kidney Int 2012; 81: 179-189
49. Levtchenko EN, van Dael CM, de Graaf-Hess AC et al. Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis. Pediatr Nephrol 2006; 21: 110-113
50. Besouw MT, Bowker R, Dutertre JP et al. Cysteamine toxicity in patients with cystinosis. J Pediatr 2011; 159: 1004-1011
51. Gahl WA, Thoene J, Schneider JA. Cystinosis: a disorder of lysosomal membrane transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B (eds). The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill, c. 199, 2001, pp. 5085-5108
52. Nesterova G, Gahl W. Nephropathic cystinosis: late complications of a multisystemic disease. Pediatr Nephrol 2008; 23: 863-878
53. Gahl WA, Balog JZ, Kleta R. Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy. Ann Intern Med 2007; 147: 242-250
54. Sonies BC, Almajid P, Kleta R et al. Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy. Medicine (Baltimore) 2005; 84: 137-146
55. Kimonis VE, Troendle J, Rose SR et al. Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis. J Clin Endocrinol Metab 1995; 80: 3257-3261
56. Kleta R, Bernardini I, Ueda M et al. Long-term follow-up of well-treated nephropathic cystinosis patients. J Pediatr 2004; 145: 555-560
57. Gahl WA, Kuehl EM, Iwata F et al. Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. Mol Genet Metab 2000; 71: 100-120
58. Tsilou E, Zhou M, Gahl W et al. Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literature. Surv Ophthalmol 2007; 52: 97-105
59. Labbé A, Niaudet P, Loirat C et al. In vivo confocal microscopy and anterior segment optical coherence tomography analysis of the cornea in nephropathic cystinosis. Ophthalmology 2009; 116: 870-876
60. Labbé A, Baudouin C, Deschênes G et al. A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: the Cystadrops OCT-1 study. Mol Genet Metab 2014; 111: 314-320
61. Spear GS, Gubler MC, Habib R et al. Renal allografts in cystinosis and mesangial demography. Clin Nephrol 1989; 32: 256-261
62. Langman CB, Greenbaum LA, Sarwal M et al. A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety. Clin J Am Soc Nephrol 2012; 7: 1112-1120
63. Langman C, Rioux P, Greenbaum L et al. Extended treatment of patients with cystinosis and CKD with RP103 demonstrates efficacy and safety. Pediatr Nephrol 2013; 28: 1363
64. Nevo N, Chol M, Bailleux A et al. Renal phenotype of the cystinosis mouse model is dependent upon genetic background. Nephrol Dial Transplant 2010; 25: 1059-1066
65. Syres K, Harrison F, Tadlock M et al. Successful treatment of the murine model of cystinosis using bone marrow cell transplantation. Blood 2009; 114: 2542-2552
66. Yeagy BA, Harrison F, Gubler MC et al. Kidney preservation by bone marrow cell transplantation in hereditary nephropathy. Kidney Int 2011; 79: 1198-1206
67. Iglesias DM, El-Kares R, Taranta A et al. Stem cell microvesicles transfer cystinosin to human cystinotic cells and reduce cystine accumulation in vitro. PLoS One 2012; 7: e42840
68. Harrison F, Yeagy BA, Rocca CJ et al. Hematopoietic stem cell gene therapy for the multisystemic lysosomal storage disorder cystinosis. Mol Ther 2013; 21: 433-444
69. van der Worp HB, Howells DW, Sena ES et al. Can animal models of disease reliably inform human studies? PLoS Med 2010; 7: e1000245